Banco Santander S.A. Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Banco Santander S.A. bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,624 shares of the pharmacy operator’s stock, valued at approximately $136,000.

Other large investors have also added to or reduced their stakes in the company. First Financial Corp IN lifted its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co lifted its holdings in Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares during the period. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter worth about $28,000. Finally, TD Private Client Wealth LLC grew its stake in shares of Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares during the period. Institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on WBA. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Truist Financial reduced their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Stock Down 1.0 %

Shares of WBA opened at $11.28 on Tuesday. The business’s 50 day moving average is $10.68 and its 200 day moving average is $9.72. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.05. The company has a market capitalization of $9.75 billion, a PE ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 earnings per share. Research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.